Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

IntroductionApathy is common in neurocognitive disorders (NCD) but NCD-specific diagnostic criteria are needed.MethodsThe International Society for CNS Clinical Trials Methodology Apathy Work Group convened an expert group and sought input from academia, health-care, industry, and regulatory bodies. A modified Delphi methodology was followed, and included an extensive literature review, two surveys, and two meetings at international conferences, culminating in a consensus meeting in 2019.ResultsThe final criteria reached consensus with more than 80% agreement on all parts and included: limited to people with NCD; symptoms persistent or frequently recurrent over at least 4 weeks, a change from the patient's usual behavior, and including one of the following: diminished initiative, diminished interest, or diminished emotional expression/responsiveness; causing significant functional impairment and not exclusively explained by other etiologies.DiscussionThese criteria provide a framework for defining apathy as a unique clinical construct in NCD for diagnosis and further research.

Original publication

DOI

10.1002/alz.12358

Type

Journal article

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association

Publication Date

12/2021

Volume

17

Pages

1892 - 1904

Addresses

Signant Health, Blue Bell, Pennsylvania, USA.

Keywords

Humans, Emotions, Motivation, Consensus, Expert Testimony, Delphi Technique, Apathy, Neurocognitive Disorders